Reduced insulin sensitivity in differentiated thyroid cancer patients with suppressed TSH.
Thaís Gomes De MeloAglecio Luiz SouzaElizabeth FicherArlete Maria FernandesLigia Vera Montali Da AssumpçãoSarah Monte AlegreDenise Engelbrecht Zantut-WittmannPublished in: Endocrine research (2017)
This study shows for the first time that subclinical thyrotoxicosis in patients with thyroid cancer is associated with insulin resistance, as measured by hyperinsulinemic-euglycemic clamp technique. Such finding may be taken into consideration by clinicians when balancing risks and benefits of TSH-suppression therapy in thyroid cancer patients.